BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 20, 2011
View Archived Issues
Polyphor prepares novel chemokine CCR10 receptor antagonists
Read More
New deuterated HCV NS5B inhibitors presented by Roche
Read More
Preliminary phase II data show activity of quizartinib in FLT3-ITD+ AML
Read More
MMP-23 level in melanoma tumors correlates with response to immune biologics
Read More
Zydux-Cadila patents novel factor Xa inhibitors
Read More
Sanofi patents new inhibitors of PDGF-R-beta and FLT-3
Read More
New antiviral agents disclosed by Hetero Research Foundation
Read More
Encouraging survival data from phase II bavituximab combination trial in NSCLC
Read More
PharmaGap reports significant efficacy improvement for enhanced GAP-107B8
Read More
ARIAD reports preclinical data on anticancer candidate AP-26113
Read More
NeurogesX completes enrollment in phase II NGX-1998 trial in postherpetic neuralgia
Read More
Phase I data support safety and possible activity of Rheumavax in rheumatoid arthritis
Read More
MR-1 Fab' PEG shows promise in murine model of arthritis
Read More
SRX-246 is safe and well tolerated in phase I study
Read More
Phase I results reported on renin inhibitor VTP-27999
Read More
Clinical development begins for Inviragen's INV-21 vaccine for hand, foot and mouth disease
Read More
Alkermes begins ALKS-5461 study in treatment-resistant depression
Read More
European Commission approves Cinryze for hereditary angioedema
Read More
Aradigm reports promising data from ORBIT-1 trial in non-CF bronchiectasis
Read More
Pearl Therapeutics begins new clinical studies of bronchodilator combination product
Read More
Nycomed gains Asia-Pacific marketing rights to Bonviva from Roche
Read More
Cordis to exit drug-eluting stent market
Read More
Activus and Gifu Pharmaceutical University to collaborate on Activus Pure Nanoparticle Technology
Read More
Alexion to conduct clinical study of Soliris in STEC-HUS in response to EHEC outbreak in Germany
Read More
Ischemix's phase IIa trial of cardioprotective drug candidate CMX-2043 meets primary endpoint
Read More
Novo Nordisk issues reminder of risks associated with Victoza
Read More